Literature DB >> 32235794

Knowledge of Rare Respiratory Diseases among Paediatricians and Medical School Students.

María Ángeles Requena-Fernández1, Francisco Dasí2,3, Silvia Castillo2,4, Rafael Barajas-Cenobi2, María Mercedes Navarro-García2, Amparo Escribano2,4,5.   

Abstract

Alpha-1-antitrypsin deficiency (AATD) and primary ciliary dyskinesia (PCD) are underdiagnosed rare diseases showing a median diagnostic delay of five to ten years, which has negative effects on patient prognosis. Lack of awareness and education among healthcare professionals involved in the management of these patients have been suggested as possible causes. Our aim was to assess knowledge of these diseases among paediatricians and medical school students to determine which knowledge areas are most deficient. A survey was designed with questions testing fundamental aspects of the diagnosis and treatment of AATD and PCD. A score equal to or greater than 50% of the maximum score was set as the level necessary to ensure a good knowledge of both diseases. Our results indicate a profound lack of knowledge of rare respiratory diseases among paediatric professionals and medical students, suggesting that it is necessary to increase rare respiratory diseases training among all physicians responsible for suspecting and diagnosing them; this will allow early diagnosis and the setup of preventive measures and appropriate early-stage treatment. The first step in closing this knowledge gap could be to include relevant material in the medical syllabus.

Entities:  

Keywords:  alpha-1 antitrypsin deficiency; primary ciliary dyskinesia; rare respiratory diseases

Year:  2020        PMID: 32235794     DOI: 10.3390/jcm9030869

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  1 in total

1.  Special Issue: Rare Respiratory Diseases: A Personal and Public Health Issue.

Authors:  María Magallón; Lucía Bañuls; Silvia Castillo; María Mercedes Navarro-García; Cruz González; Francisco Dasí
Journal:  J Clin Med       Date:  2021-12-16       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.